YourEncore Helps Pharma Companies Reduce Risk, Improve Results of Phase III Trials

  YourEncore Helps Pharma Companies Reduce Risk, Improve Results of Phase III

Independent Challenge Teams provide unbiased, expert assessments before drugs
                               enter Phase III

Business Wire

INDIANAPOLIS -- November 13, 2012

YourEncore, a leading provider of expert solutions to the life sciences and
consumer product industries, today launched a new solution that will help
pharmaceutical companies make more informed decisions about whether and how to
proceed with Phase III trials.

“The stakes couldn’t be higher, yet nearly four in 10 drugs in Phase III fail
to get approval,” said Lisa M. Arbogast, YourEncore’s VP for Life Sciences.
“Our Independent Challenge Teams (ICTs) provide an unbiased expert perspective
that can help a company avoid failures during this critical stage of testing.”

YourEncore hand-selects teams of leading clinical, regulatory, commercial and
market access experts for each project based on disease and therapeutic areas
of expertise. After a rigorous study of the data, the team assesses the
likelihood of success in Phase III and may recommend changes in protocol
design, labeling and claims to increase the odds of approval.

Companies typically spend hundreds of millions of dollars in Phase III, while
facing intense scrutiny from Wall Street and regulators. As a result, failures
can have a devastating impact on a drug-maker’s reputation and financial
position. YourEncore provides critical insights that allow companies to make
better-informed go/no-go decisions prior to entering Phase III.

A company’s in-house researchers may spend years developing a compound and
often have significant personal and professional investments in its success.
ICTs, whose members average 25 years of experience, can provide an unbiased,
fresh look at a drug before it enters the most costly and high profile phase
of trials.

“Drug companies today are under extreme pressure to deliver the next
blockbuster,” said Arbogast. “YourEncore provides a level of expertise and
objectivity that is critical to success in the regulatory process and the

About YourEncore

Indianapolis-based YourEncore accelerates innovation and growth for companies
in the life sciences and consumer product industries. The company’s 7,500+
veteran-level experts include top-flight professionals, with an average of 25
years of industry experience. By providing perfectly-matched expertise and
flexible solutions, YourEncore helps research, develop and commercialize
products for Procter & Gamble, Lilly, Boeing, General Mills and nearly 70
other global Fortune 500 leaders. For more information, visit and follow facebook/yourencore.


Michael Rubin, 202-898-0995
Press spacebar to pause and continue. Press esc to stop.